# EDGAR Filing Document

**Accession Number:** 0000019617
**File Stem:** 0001213900-25-049613
**Filing Date:** 2025-6
**Character Count:** 10981
**Document Hash:** 11a863272963db927f20129842534438
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-049613.hdr.sgml**: 20250602

**ACCESSION NUMBER**: 0001213900-25-049613

**CONFORMED SUBMISSION TYPE**: FWP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250602

**DATE AS OF CHANGE**: 20250530

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMORGAN CHASE & CO
- **CENTRAL INDEX KEY:** 0000019617
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 132624428
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-270004
- **FILM NUMBER:** 251012662

**BUSINESS ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 2122706000

**MAIL ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** J P MORGAN CHASE & CO
- **DATE OF NAME CHANGE:** 20010102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHASE MANHATTAN CORP /DE/
- **DATE OF NAME CHANGE:** 19960402

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHEMICAL BANKING CORP
- **DATE OF NAME CHANGE:** 19920703
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMORGAN CHASE & CO
- **CENTRAL INDEX KEY:** 0000019617
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 132624428
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP

**BUSINESS ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 2122706000

**MAIL ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** J P MORGAN CHASE & CO
- **DATE OF NAME CHANGE:** 20010102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHASE MANHATTAN CORP /DE/
- **DATE OF NAME CHANGE:** 19960402

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHEMICAL BANKING CORP
- **DATE OF NAME CHANGE:** 19920703

****

**JPMorgan Chase Financial Company LLC**

Free Writing Prospectus Filed Pursuant to Rule 433

Registration Statement Nos. 333-270004 and 333-270004-01

Dated May 30, 2025

3-Year TPX PLUS

***This document provides a summary of the terms of the PLUS. Investors must carefully review the accompanying preliminary pricing supplement referenced below, product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum and the "Risk Considerations" on the following page, prior to making an investment decision.***

---

| | |
|:---|:---|
| &nbsp;&nbsp;**SUMMARY TERMS** | &nbsp;&nbsp;**SUMMARY TERMS** |
| &nbsp;&nbsp;**Issuer:** | JPMorgan Chase Financial Company LLC ("JPMorgan Financial") |
| &nbsp;&nbsp;**Guarantor:** | JPMorgan Chase & Co. |
| &nbsp;&nbsp;**Underlying index:** | TOPIX<sup>®</sup> Index (Bloomberg ticker: TPX Index) |
| &nbsp;&nbsp;**Payment at maturity:** | &nbsp;&nbsp;&nbsp;&nbsp; If the final index value is *greater than* the initial index value, for each $1,000 stated principal amount PLUS,<br> $1,000 + leveraged upside payment<br>If the final index value is *less than or equal to* the initial index value, for each $1,000 stated principal amount PLUS,<br> $1,000 × index performance factor<br> *This amount will be less than or equal to the stated principal amount of $1,000 per PLUS.* |
| &nbsp;&nbsp;**Leveraged upside payment:** | $1,000 × leverage factor × index percent increase |
| &nbsp;&nbsp;**Index percent increase:** | (final index value – initial index value) / initial index value |
| &nbsp;&nbsp;**Initial index value:** | The closing level of the underlying index on the pricing date |
| &nbsp;&nbsp;**Final index value:** | The closing level of the underlying index on the valuation date |
| &nbsp;&nbsp;**Leverage factor:** | At least 190.00% |
| &nbsp;&nbsp;**Index performance factor:** | final index value / initial index value |
| &nbsp;&nbsp;**Stated principal amount:** | $1,000 per PLUS |
| &nbsp;&nbsp;**Issue price:** | $1,000 per PLUS |
| &nbsp;&nbsp;**Pricing date:** | Expected to be June 3, 2025 |
| &nbsp;&nbsp;**Original issue date (settlement date):** | 3 business days after the pricing date |
| &nbsp;&nbsp;**Valuation date<sup>†</sup>:** | June 5, 2028 |
| &nbsp;&nbsp;**Maturity date<sup>†</sup>:** | June 8, 2028 |
| &nbsp;&nbsp;**CUSIP / ISIN:** | 48136EPF6 / US48136EPF69 |
| &nbsp;&nbsp;**Preliminary pricing supplement:** | [http://www.sec.gov/Archives/edgar/data/19617/<br> 000121390025049328/ea0244058-01_424b2.htm](http://www.sec.gov/Archives/edgar/data/19617/000121390025049328/ea0244058-01_424b2.htm) |

---

<sup>†</sup>Subject to postponement

The estimated value of the PLUS on the pricing date will be provided in the pricing supplement and will not be less than $930.00 per $1,000 stated principal amount PLUS. For information about the estimated value of the PLUS, which likely will be lower than the price you paid for the PLUS, please see the hyperlink above.

Any payment on the PLUS is subject to the credit risk of JPMorgan Financial as issuer of the PLUS, and the credit risk of JPMorgan Chase & Co., as guarantor of the PLUS.

---

| |
|:---|
| **PLUS Payoff Diagram\*** |
| &nbsp;&nbsp;![](image_001.jpg) |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Change in Underlying Index** | &nbsp;&nbsp;**Return on the PLUS\*** |
| &nbsp;&nbsp;50.00% | &nbsp;&nbsp;95.00% |
| &nbsp;&nbsp;40.00% | &nbsp;&nbsp;76.00% |
| &nbsp;&nbsp;30.00% | &nbsp;&nbsp;57.00% |
| &nbsp;&nbsp;20.00% | &nbsp;&nbsp;38.00% |
| &nbsp;&nbsp;10.00% | &nbsp;&nbsp;19.00% |
| &nbsp;&nbsp;5.00% | &nbsp;&nbsp;9.50% |
| &nbsp;&nbsp;1.00% | &nbsp;&nbsp;1.90% |
| &nbsp;&nbsp;0.00% | &nbsp;&nbsp;0.00% |
| &nbsp;&nbsp;-10.00% | &nbsp;&nbsp;-10.00% |
| &nbsp;&nbsp;-20.00% | &nbsp;&nbsp;-20.00% |
| &nbsp;&nbsp;-30.00% | &nbsp;&nbsp;-30.00% |
| &nbsp;&nbsp;-40.00% | &nbsp;&nbsp;-40.00% |
| &nbsp;&nbsp;-50.00% | &nbsp;&nbsp;-50.00% |
| &nbsp;&nbsp;-60.00% | &nbsp;&nbsp;-60.00% |
| &nbsp;&nbsp;-80.00% | &nbsp;&nbsp;-80.00% |
| &nbsp;&nbsp;-100.00% | &nbsp;&nbsp;-100.00% |
| &nbsp;&nbsp;*\*Assumes a leverage factor of 190.00%. The actual leverage factor will be provided in the pricing supplement and will not be less than 190.00%* | &nbsp;&nbsp;*\*Assumes a leverage factor of 190.00%. The actual leverage factor will be provided in the pricing supplement and will not be less than 190.00%* |

---

**JPMorgan Chase Financial Company LLC**

3-Year TPX PLUS

Underlying Index

For more information about the underlying index, including historical performance information, see the accompanying preliminary pricing supplement.

Risk Considerations

The risks identified below are not exhaustive. Please see "Risk Factors" in the accompanying prospectus supplement, product supplement and preliminary pricing supplement and Annex A to the accompanying prospectus addendum for additional information.

Risks Relating to the PLUS Generally

▪ The PLUS do not pay interest or guarantee the return of any principal and your investment in the PLUS
may result in a loss.

▪ The PLUS are subject to the credit risks of JPMorgan Financial and JPMorgan Chase & Co., and any
actual or anticipated changes to our or JPMorgan Chase & Co.'s credit ratings or credit spreads may adversely affect the market
value of the PLUS.

▪ As a finance subsidiary, JPMorgan Financial has no independent operations and has limited assets.

▪ Secondary trading may be limited.

▪ We may accelerate your PLUS in our sole discretion and the calculation agent may adjust their final payment
in good faith and in a commercially reasonable manner if a change-in-law event occurs.

▪ The final terms and estimated valuation of the PLUS will be provided in the pricing supplement.

▪ The tax consequences of an investment in the PLUS are uncertain.

Risks Relating to Conflicts of Interest

▪ Economic interests of the issuer, the guarantor, the calculation agent, the agent of the offering of
the PLUS and other affiliates of the issuer may be different from those of investors.

▪ Hedging and trading activities by the issuer and its affiliates could potentially affect the value of
the PLUS.

Risks Relating to the Estimated Value and Secondary Market Prices of the PLUS

▪ The estimated value of the PLUS will be lower than the original issue price (price to public) of the
PLUS .

▪ The estimated value of the PLUS does not represent future values of the PLUS and may differ from others'
estimates .

▪ The estimated value of the PLUS is derived
by reference to an internal funding rate.

▪ The value of the PLUS as published by
J.P. Morgan Securities LLC (and which may be reflected on customer account statements) may be higher than the then-current estimated value
of the PLUS for a limited time period.

▪ Secondary market prices of the PLUS will likely be lower than the original issue price of the PLUS .

▪ Secondary market prices of the PLUS will
be impacted by many economic and market factors.

Risks Relating to the Underlying Index

▪ Investing in the PLUS is not equivalent to investing in the underlying index.

▪ Adjustments to the underlying index could adversely affect the value of the PLUS.

▪ The PLUS are subject to risks associated
with securities issued by non-U.S. companies.

▪ The PLUS are not directly exposed to fluctuations in foreign exchange rates.

▪ Governmental legislative and regulatory actions, including sanctions, could adversely affect your investment
in the PLUS.

Tax Considerations

You should review carefully the discussion in the accompanying preliminary pricing supplement under "Additional Information about the PLUS — Tax considerations" concerning the U.S. federal income tax consequences of an investment in the PLUS, and you should consult your tax adviser.

SEC Legend: JPMorgan Chase Financial Company LLC and JPMorgan Chase & Co. have filed a registration statement (including a prospectus) with the SEC for any offerings to which these materials relate. Before you invest, you should read the prospectus in that registration statement and the other documents relating to this offering that JPMorgan Chase Financial Company LLC and JPMorgan Chase & Co. has filed with the SEC for more complete information about JPMorgan Chase Financial Company LLC and JPMorgan Chase & Co. and this offering. You may get these documents without cost by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, JPMorgan Chase Financial Company LLC and JPMorgan Chase & Co., any agent or any dealer participating in the this offering will arrange to send you the prospectus and each prospectus supplement as well as any product supplement, underlying supplement and preliminary pricing supplement if you so request by calling toll-free 1-866-535-9248.